Makoto Katoh

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Community Dwelling

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

Geriatrics (Basel, Switzerland)

Diabetes therapy : research, treatment and education of diabetes and related disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Kenta Tsutsui, Shoko Ukita, Masahiro Kondo, Genta Toshima, Naoki Miyazaki, Kengo Nagashima, Mitsuyo Ohmura, Saki Tsuchihashi, Yoshitaka Tsuji, Makoto Katoh, Naomi Aida, Yoshiki Kobayashi, Yui Ohtsu, Yoshihiro Fujita, Shukichi Tanaka, Hiroki Watanabe, Yasushi Naruse, Isao Iizuka, Hiromi Kato, Yumi Mashimo, Takaaki Senbonmatsu
Synergistic Effect of Motivation for the Elderly and Support for Going Out II: Measures to Induce Elderly Men to Go Out. Geriatrics (Basel, Switzerland) 9 (1) (2024)
Kenta Tsutsui, Shoko Ukita, Masahiro Kondo, Genta Toshima, Naoki Miyazaki, Kengo Nagashima, Mitsuyo Ohmura, Saki Tsuchihashi, Yoshitaka Tsuji, Makoto Katoh, Naomi Aida, Yoshiki Kobayashi, Yui Ohtsu, Yoshihiro Fujita, Shukichi Tanaka, Hiroki Watanabe, Yasushi Naruse, Isao Iizuka, Hiromi Kato, Yumi Mashimo, Takaaki Senbonmatsu
Synergistic Effect of Motivation for the Elderly and Support for Going Out II: Measures to Induce Elderly Men to Go Out. Geriatrics (Basel, Switzerland) 9 (1) (2024)
Kenta Tsutsui, Shoko Ukita, Masahiro Kondo, Genta Toshima, Naoki Miyazaki, Kengo Nagashima, Mitsuyo Ohmura, Saki Tsuchihashi, Yoshitaka Tsuji, Makoto Katoh, Naomi Aida, Yoshiki Kobayashi, Yui Ohtsu, Yoshihiro Fujita, Shukichi Tanaka, Hiroki Watanabe, Yasushi Naruse, Isao Iizuka, Hiromi Kato, Yumi Mashimo, Takaaki Senbonmatsu
Synergistic Effect of Motivation for the Elderly and Support for Going Out II: Measures to Induce Elderly Men to Go Out. Geriatrics (Basel, Switzerland) 9 (1) (2024)
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Norie Watahiki, Satako Douguchi, Kensuke Ofuchi, Makoto Katoh
Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Norie Watahiki, Satako Douguchi, Kensuke Ofuchi, Makoto Katoh
Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Takeshi Osonoi, Miyoko Saito, Naoya Koda, Satako Douguchi, Takako Nakano, Kensuke Ofuchi, Makoto Katoh
Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
Takeshi Osonoi, Atsuko Tamasawa, Yusuke Osonoi, Kensuke Ofuchi, Makoto Katoh, Miyoko Saito
Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 10 (6) (2019)